Sultan Mayar

· Led the design and cross functional collaboration with external institutions for more than 6 peer-reviewed publications.

· Experience in engaging with KOLs in the neurology, cardiology, and pharmacology field through presenting scientific findings at 10+ international and national conferences.

· Organized and host for 2024 Biophysical Society of Canada (BSC) in Montreal, Canada and active member of the international Biophysical Society (BPS).

· Managed and mentored more than 10 students, fostering academic and professional growth through peer-to-peer scientific discussions.

· Examined the molecular action of cardiac and neurological protein targets by novel cannabinoids.

• Cross functional collaboration with Neuractas Therapeutics (funded by Mitacs Accelerate Program) for the pre-clinical development of a novel anticonvulsant for epilepsy.
• Experienced in scientific discussions with KOLs, HCPs and key stakeholders in Avicanna, to plan for the clinical applications of cannabinoids as anticonvulsants using human cerebral organoids from patient-derived iPSCs.
• Provided insights into the mechanism of action of cannabinoids in various neurological disorders.

• Conducted sterile water sampling and monitored air particle qualification, ensuring compliance with SOPs and GMP in controlled environments.
• Collaborated with laboratory technicians adhere to proper Grade C and D environments.
• Performed diagnostic tests to identify malfunctions and implement solutions.

• Developed finished product specifications for new vaccines and over the counter pharmaceuticals.
• Adhered to SOP and GMP protocols for quality of finished products using Canadian regulatory processes in a pharmaceutical setting and worked closely with the medical affairs team.
• Worked closely with research and development to assign detailed analysis of products.
• Assessed quality of finished products with careful inspections.